The Mental Health TALK SAFE Act of 2026 aims to modernize the regulations surrounding the prescription of controlled substances through telehealth, particularly for mental health treatments. The legislation seeks to enhance access to necessary medications for patients while ensuring safety and proper oversight in the prescribing process. Key provisions include the requirement that telehealth practitioners conduct at least one evaluation of a patient before issuing a valid prescription for controlled substances.